Patents by Inventor Dana Hilt

Dana Hilt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptors in Combination with Acetylcholinesterase Inhibitors
    Publication number: 20150126546
    Abstract: A method for improving cognition comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof and an acetylcholinesterase inhibitor is described together with related compositions.
    Type: Application
    Filed: June 17, 2014
    Publication date: May 7, 2015
    Inventors: Gerhard Koenig, Dana Hilt
  • Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Acetylcholinesterase Inhibitors
    Publication number: 20130225560
    Abstract: A method for improving cognition comprising administering to a patient certain alpha-7 receptor agonists and an acetylcholinesterase inhibitor is described together with related compositions.
    Type: Application
    Filed: July 25, 2011
    Publication date: August 29, 2013
    Applicant: ENVIVO PHARMACEUTICALS, INC.
    Inventors: Gerhard Koenig, Dana Hilt
  • TREATMENT OF COGNITIVE DISORDERS WITH CERTAIN ALPHA-7 NICOTINIC ACID RECEPTORS IN COMBINATION WITH ACETYLCHOLINESTERASE INHIBITORS
    Publication number: 20110124631
    Abstract: A method for improving cognition comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof and an acetylcholinesterase inhibitor is described together with related compositions.
    Type: Application
    Filed: December 27, 2010
    Publication date: May 26, 2011
    Inventors: Gerhard Koenig, Dana Hilt
  • Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
    Patent number: 7767717
    Abstract: The present invention provides a method for treating or preventing excessive scarring, including keloid and hypertrophic scars, by administering 4-hydroxy tamoxifen to a patient with excessive scarring or a wound at risk for developing excessive scarring.
    Type: Grant
    Filed: June 2, 2004
    Date of Patent: August 3, 2010
    Assignees: Ascend Therapeutics, Inc., Northwestern University
    Inventors: Andrew Palumbo, Julius Few, Dana Hilt
  • Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
    Publication number: 20050238616
    Abstract: The present invension relates to compositions of a biocompatible polymer and a antineoplastic agent for treating central nervous system neoplasms, and methods of using and making the same. In certain embodiments, the polymer contains phosphorous linkages. In other embodiments, the antineoplastic agent is an antineoplastic taxane. In still other embodiments, the subject methods of treatment use electromagnetic radiation.
    Type: Application
    Filed: January 9, 2003
    Publication date: October 27, 2005
    Applicant: Guilford Pharmaceuticals, Inc.
    Inventors: Wenbin Dang, Dana Hilt, William Vincek
  • Chemically stable compositions of 4-hydroxy tamoxifen
    Publication number: 20050208139
    Abstract: A class of chemically stable 4-hydroxy tamoxifen compositions is characterized by roughly equal amounts of the Z-4-hydroxy tamoxifen and E-4-hydroxy tamoxifen isomers, such that the potency of the compositions is not affected adversely by the isomerization that occurs between these two forms. The inventive compositions are useful for preventing or for treating medical conditions.
    Type: Application
    Filed: March 22, 2004
    Publication date: September 22, 2005
    Inventors: Dana Hilt, Valerie Masini, Richard Fedynec, Brigitte Taravella
  • Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
    Publication number: 20050032910
    Abstract: The present invention provides a method for treating or preventing excessive scarring, including keloid and hypertrophic scars, by administering 4-hydroxy tamoxifen to a patient with excessive scarring or a wound at risk for developing excessive scarring.
    Type: Application
    Filed: June 2, 2004
    Publication date: February 10, 2005
    Inventors: Andrew Palumbo, Julius Few, Dana Hilt
  • Compositions for treatment of head and neck cancers, and methods of making and using the same
    Publication number: 20030134892
    Abstract: The present invention relates to compositions of a biocompatible polymer and an antineoplastic agent, and methods of using and making the same, for the treatment of head and neck cancers. In certain embodiments, the polymer contains phosphorous linkages. In other embodiments, the antineoplastic agent is an antineoplastic taxane.
    Type: Application
    Filed: July 19, 2002
    Publication date: July 17, 2003
    Inventors: Wenbin Dang, Dana Hilt